Days after a panel of experts advised the use of the products in areas where strains of the coronavirus are circulating, the United Nations health agency identified the COVID-19 vaccine developed by the University of Oxford and drugmaker AstraZeneca for emergency use.
On Monday, a statement by the World Health Organization (WHO) said the relatively inexpensive shot developed by AstraZeneca-SKBio (South Korea) and the Serum Institute of India had been approved.
Tedros Adhanom Ghebreyesus, WHO director-general said that they are now ready for the rapid distribution of vaccines, But still got to proportion production.
He also added that the COVID-19 vaccine developers have to submit their dossiers to WHO. They have to do so for review at an equivalent time as they submit them to regulators in high-income countries.
Related
Data source: Al Jazeera